RSS feed

Publications by Knut P. Nordal

62 publications found

Original articles

Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, Nordal KP, Jenssen T (2004)
Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation
Diabetologia, 47 (9), 1550-6
DOI 10.1007/s00125-004-1499-z, PubMed 15338129

Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, Degré M, Fauchald P, Rollag H (2004)
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
Kidney Int, 66 (1), 329-37
DOI 10.1111/j.1523-1755.2004.00735.x, PubMed 15200441

Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Asberg A, Degré M, Fauchald P, Rollag H (2003)
Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study
Nephrol Dial Transplant, 18 (9), 1899-908
DOI 10.1093/ndt/gfg302, PubMed 12937241

Sagedal S, Nordal KP, Hartmann A, Sund S, Scott H, Degré M, Foss A, Leivestad T, Osnes K, Fauchald P, Rollag H (2002)
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
Am J Transplant, 2 (9), 850-6
DOI 10.1034/j.1600-6143.2002.20907.x, PubMed 12392291

Rollag H, Sagedal S, Kristiansen KI, Kvale D, Holter E, Degré M, Nordal KP (2002)
Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
Clin Microbiol Infect, 8 (7), 431-4
DOI 10.1046/j.1469-0691.2002.00449.x, PubMed 12199854

Midtvedt K, Hartmann A, Foss A, Fauchald P, Nordal KP, Rootwelt K, Holdaas H (2001)
Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril
Transplantation, 72 (11), 1787-92
DOI 10.1097/00007890-200112150-00013, PubMed 11740389

Degré M, Kristiansen KI, Rollag H, Holter E, Nordal KP (2001)
Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients
Clin Microbiol Infect, 7 (5), 254-60
DOI 10.1046/j.1198-743x.2001.00251.x, PubMed 11422252

Fritsche L, Vanrenterghem Y, Nordal KP, Grinyo JM, Moreso F, Budde K, Kunz R, Meyerrose B, Neumayer HH (2000)
Practice variations in the evaluation of adult candidates for cadaveric kidney transplantation: a survey of the European Transplant Centers
Transplantation, 70 (10), 1492-7
DOI 10.1097/00007890-200011270-00017, PubMed 11118096

Sagedal S, Nordal KP, Hartmann A, Degré M, Holter E, Foss A, Osnes K, Leivestad T, Fauchald P, Rollag H (2000)
A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients
Transplantation, 70 (8), 1166-74
DOI 10.1097/00007890-200010270-00007, PubMed 11063335

Nordøy I, Müller F, Nordal KP, Rollag H, Aukrust P, Frøland SS (2000)
Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection
Clin Exp Immunol, 120 (2), 333-7
DOI 10.1046/j.1365-2249.2000.01221.x, PubMed 10792384

Fritsche L, Nordal KP, Vanrenterghem Y, Grinyo JM, Moreso F, Budde K, Neumayer HH (2000)
Different diagnostic approaches to adult candidates for cadaveric kidney transplantation in Europe
Transpl Int, 13 Suppl 1, S263-6
DOI 10.1007/s001470050338, PubMed 11112009

Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Froland SS (2000)
The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients
J Infect Dis, 181 (1), 51-7
DOI 10.1086/315184, PubMed 10608750

Gullestad L, Nordal KP, Berg KJ, Cheng H, Schwartz MS, Simonsen S (1999)
Interaction between lovastatin and cyclosporine A after heart and kidney transplantation
Transplant Proc, 31 (5), 2163-5
DOI 10.1016/s0041-1345(99)00295-x, PubMed 10456002

Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Frøland SS (1999)
Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients
J Infect Dis, 180 (1), 195-8
DOI 10.1086/314849, PubMed 10353879

Lehne G, Nordal KP, Midtvedt K, Goggin T, Brosstad F (1998)
Increased potency and decreased elimination of lamifiban, a GPIIb-IIIa antagonist, in patients with severe renal dysfunction
Thromb Haemost, 79 (6), 1119-25
PubMed 9657435

Rollag H, Sagedal S, Holter E, Degré M, Ariansen S, Nordal KP (1998)
Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes
Eur J Clin Microbiol Infect Dis, 17 (2), 124-7
DOI 10.1007/BF01682170, PubMed 9629980

Gullestad L, Nordal KP, Forfang K, Ihlen H, Høstmark A, Berg KJ, Cheng H, Schwartz MS, Geiran O, Simonsen S (1997)
Post-transplant hyperlipidaemia: low-dose lovastatin lowers atherogenic lipids without plasma accumulation of lovastatin
J Intern Med, 242 (6), 483-90
DOI 10.1111/j.1365-2796.1997.tb00021.x, PubMed 9437409

Nordal KP, Hartmann A, Leivestad T, Halvorsen S, Iversen BM, Widerøe TE, Julsrud J (1996)
[Critical shortage of personnel in nephrology. Assessment of causes of the crisis and suggestion for solution]
Tidsskr Nor Laegeforen, 116 (28), 3348-51
PubMed 9011993

Midtvedt K, Tafjord AB, Hartmann A, Eide TC, Holdaas H, Nordal KP, Draganov B, Sødal G, Leivestad T, Fauchald P (1996)
Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection
Transplantation, 62 (1), 38-42
DOI 10.1097/00007890-199607150-00008, PubMed 8693541

Dahl E, Nordal KP, Halse J (1996)
Predialysis calcitriol administration: effects on pre- and post-transplant renal osteodystrophy
J Intern Med, 239 (6), 537-40
DOI 10.1046/j.1365-2796.1996.428780000.x, PubMed 8656148

Jakobsen JA, Berg KJ, Kjaersgaard P, Kolmannskog F, Nordal KP, Nossen JO, Rootwelt K (1996)
Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention
Nephron, 73 (4), 549-56
DOI 10.1159/000189139, PubMed 8856250

Berg KJ, Lundby B, Reinton V, Nordal KP, Rootwelt K, Smith HJ (1996)
Gadodiamide in renal transplant patients: effects on renal function and usefulness as a glomerular filtration rate marker
Nephron, 72 (2), 212-7
DOI 10.1159/000188844, PubMed 8684529

Wahlberg J, Wilczek HE, Fauchald P, Nordal KP, Heaf JG, Olgaard K, Hansen JM, Lokkegaard H, Mueller EA, Kovarik JM (1995)
Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period
Transplantation, 60 (7), 648-52
DOI 10.1097/00007890-199510150-00005, PubMed 7570970

Halse J, Falch J, Haug E, Jorde R, Nesheim BI, Nordal KP, Skjaeraasen J, Aanderud S (1995)
[Osteoporosis drugs prescribed on blue forms!]
Tidsskr Nor Laegeforen, 115 (24), 3050-1
PubMed 7570539

Simonsen S, Gullestad L, Forfang K, Ihlen H, Nordal KP, Geiran O, Høstmark AT (1995)
[Hypercholesterolemia--a clinical problem in heart transplantation. A therapeutic trial with low-dose lovastatin]
Tidsskr Nor Laegeforen, 115 (3), 357-9
PubMed 7855835

Nordal KP, Dahl E, Halse J, Attramadal A, Flatmark A (1995)
Long-term low-dose calcitriol treatment in predialysis chronic renal failure: can it prevent hyperparathyroid bone disease?
Nephrol Dial Transplant, 10 (2), 203-6
PubMed 7753453

Halse J, Falch J, Jorde R, Nordal KP, Aanderud S (1994)
[Clinical use of bone mineral measurements]
Tidsskr Nor Laegeforen, 114 (23), 2706
PubMed 7998006

Bentdal OH, Brekke IB, Lien B, Pfeffer PF, Sødal G, Hartmann A, Holdaas H, Nordal KP, Fauchald P (1994)
Rapid development of cancer in both kidney grafts after transplantation from a donor with undiagnosed malignant disease
Transplant Proc, 26 (3), 1763
PubMed 8030123

Nordsletten L, Kaastad TS, Skjeldal S, Reikerås O, Nordal KP, Halse J, Ekeland A (1994)
Fracture strength prediction in rat femoral shaft and neck by single photon absorptiometry of the femoral shaft
Bone Miner, 25 (1), 39-46
DOI 10.1016/s0169-6009(08)80206-1, PubMed 8061550

Halse J, Nordal KP, Attramadal A, Dahl E (1994)
[Idiopathic osteoporosis in middle-aged men--a "new" disease?]
Tidsskr Nor Laegeforen, 114 (4), 439-42
PubMed 8009480

Halse J, Nordal KP, Knudtzon J, Stokke O, Glattre E (1993)
[Bone mineral density and occurrence of fractures in 66-year old women in Oslo]
Tidsskr Nor Laegeforen, 113 (15), 1846-8
PubMed 8322323

Svaland MG, Kolmannskog F, Lillevold PE, Nordal KP, Ressem L, Berg KJ (1992)
Pharmacokinetics of iopentol in patients with chronic renal failure
Acta Radiol, 33 (5), 482-4
PubMed 1389660

Nordal KP, Dahl E, Halse J, Aksnes L, Thomassen Y, Flatmark A (1992)
Aluminum metabolism and bone histology after kidney transplantation: a one-year follow-up study
J Clin Endocrinol Metab, 74 (5), 1140-5
DOI 10.1210/jcem.74.5.1569161, PubMed 1569161

Hartmann A, Holdaas H, Fauchald P, Nordal KP, Berg KJ, Talseth T, Leivestad T, Brekke IB, Flatmark A (1992)
Fifteen years' experience with renal transplantation in systemic amyloidosis
Transpl Int, 5 (1), 15-8
DOI 10.1007/BF00337183, PubMed 1580980

Berg KJ, Kolmannskog F, Lillevold PE, Nordal KP, Ressem L, Rootwelt K, Svaland MG (1992)
Iopentol in patients with chronic renal failure: its effects on renal function and its use as glomerular filtration rate parameter
Scand J Clin Lab Invest, 52 (1), 27-33
DOI 10.3109/00365519209085437, PubMed 1594886

Nordal KP, Dahl E, Halse J, Hartmann A, Flatmark A (1992)
Parathyroidectomy does not affect bone aluminum in chronic renal failure
Transplant Proc, 24 (1), 369-70
PubMed 1539321

Nordal KP, Dahl E, Halse J, Flatmark A (1992)
Early kidney transplantation may prevent aluminium-related bone disease
Transpl Int, 5 Suppl 1, S98-9
DOI 10.1007/978-3-642-77423-2_31, PubMed 14621745

Dahl E, Nordal KP, Halse J, Flatmark A (1992)
Pretransplant parathyroidectomy in renal failure: effects on bone histology and aluminum deposits during dialysis and after kidney transplantation
Scand J Urol Nephrol, 26 (3), 283-8
DOI 10.3109/00365599209180884, PubMed 1439604

Alexander J, Gjessing E, Nordal KP, Dahl E, Halse J, Thomassen Y (1990)
A preliminary study of aluminium in serum and other human materials in subjects from different areas of Norway
Environ Geochem Health, 12 (1-2), 83-6
DOI 10.1007/BF01734054, PubMed 24202571

Halse J, Nordal KP, Dahl E, Thomassen Y (1990)
Aluminium metabolism in chronic renat failure: Environmental influences and regional differences in Norway
Environ Geochem Health, 12 (1-2), 77-82
DOI 10.1007/BF01734053, PubMed 24202570

Dahl E, Nordal KP, Halse J, Flatmark A (1990)
The early effects of aluminium deposition and dialysis on bone in chronic renal failure: a cross-sectional bone-histomorphometric study
Nephrol Dial Transplant, 5 (6), 449-56
DOI 10.1093/ndt/5.6.449, PubMed 2122323

Dahl E, Nordal KP, Aksnes L, Halse J (1989)
Bone remodeling in predialysis chronic renal failure: how does the choice of index for mineralizing surface influence the interpretation?
J Bone Miner Res, 4 (6), 845-52
DOI 10.1002/jbmr.5650040609, PubMed 2610021

Nordal KP, Dahl E, Albrechtsen D, Halse J, Leivestad T, Tretlie S, Fauchald P, Flatmark A (1989)
Fewer rejection episodes in kidney graft recipients with aluminum accumulation in bone: an immunosuppressive effect of aluminum toxicity
Transplant Proc, 21 (1 Pt 2), 2046-7
PubMed 2652670

Nordal KP, Dahl E, Albrechtsen D, Halse J, Leivestad T, Tretli S, Flatmark A (1988)
Aluminium accumulation and immunosuppressive effect in recipients of kidney transplants
BMJ, 297 (6663), 1581-2
DOI 10.1136/bmj.297.6663.1581, PubMed 3147082

Nordal KP, Dahl E, Sørhus K, Berg KJ, Thomassen Y, Kofstad J, Halse J (1988)
Gastrointestinal absorption and urinary excretion of aluminium in patients with predialysis chronic renal failure
Pharmacol Toxicol, 63 (5), 351-4
DOI 10.1111/j.1600-0773.1988.tb00967.x, PubMed 3237594

Nordal KP, Dahl E (1988)
Low dose calcitriol versus placebo in patients with predialysis chronic renal failure
J Clin Endocrinol Metab, 67 (5), 929-36
DOI 10.1210/jcem-67-5-929, PubMed 3182964

Holdaas H, Hartmann A, Talseth T, Berg KJ, Fauchald P, Stenstrøm J, Djøseland O, Nordal KP, Brodwall E (1988)
Short-term changes in renal function of the remaining kidney after donor nephrectomy
Transplant Proc, 20 (3), 434-5
PubMed 3381255

Talseth T, Holdaas H, Albrechtsen D, Berg KJ, Fauchald P, Naalsund A, Nordal KP, Skar AG, Sødal G, Flatmark A (1988)
Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients
Transplant Proc, 20 (3), 400-1
PubMed 3289169

Holdaas H, Talseth T, Berg KJ, Fauchald P, Nordal KP, Hartmann A (1988)
Diagnostic value of peripheral plasma renin response to a single dose of captopril in suspected renal transplant artery stenosis
Transplant Proc, 20 (3), 423-4
PubMed 3289174

Dahl E, Nordal KP, Halse J, Attramadal A (1988)
Histomorphometric analysis of normal bone from the iliac crest of Norwegian subjects
Bone Miner, 3 (4), 369-77
PubMed 3228618

Nordal KP, Dahl E, Thomassen Y, Brodwall EK, Halse J (1988)
Seasonal variations in serum aluminum concentrations
Pharmacol Toxicol, 62 (2), 80-3
DOI 10.1111/j.1600-0773.1988.tb01850.x, PubMed 3353356

Dahl E, Nordal KP, Attramadal A, Halse J, Flatmark A (1988)
Renal osteodystrophy in predialysis patients without stainable bone aluminum. A cross-sectional bone-histomorphometric study
Acta Med Scand, 224 (2), 157-64
DOI 10.1111/j.0954-6820.1988.tb16754.x, PubMed 2458677

Nordal KP, Dahl E, Halse J, Sødal G, Thomassen Y, Aaseth J (1986)
Kidney transplantation may cure aluminium osteodystrophy
Acta Pharmacol Toxicol (Copenh), 59 Suppl 7, 289-92
DOI 10.1111/j.1600-0773.1986.tb02765.x, PubMed 3535375

Nordal KP, Dahl E, Halse J, Thomassen Y, Aaseth J (1986)
Calcitriol treatment does not increase the serum aluminium concentration in patients with moderate renal failure
Acta Pharmacol Toxicol (Copenh), 59 Suppl 7, 293-5
DOI 10.1111/j.1600-0773.1986.tb02766.x, PubMed 3776577

Dahl E, Nordal KP, Halse J, Attramadal A (1985)
[Histomorphometry of bone tissue]
Tidsskr Nor Laegeforen, 105 (23), 1503-7
PubMed 4049343

Nordal KP, Dahl E, Halse J, Aksnes L, Aarskog D (1985)
Rapid effect of prednisolone on serum 1,25-dihydroxycholecalciferol levels in hypercalcemic sarcoidosis
Acta Med Scand, 218 (5), 519-23
DOI 10.1111/j.0954-6820.1985.tb08883.x, PubMed 3841460

Anker E, Nordal KP (1977)
[Waldenstrom's macroglobulinemia]
Tidsskr Nor Laegeforen, 97 (30), 1556-8
PubMed 412273

Other articles

Knudtzon J, Halse J, Monn E, Nesland A, Nordal KP, Paus P, Seip M, Sund S, Sødal G (1995)
Autonomous hyperparathyroidism in X-linked hypophosphataemia
Clin Endocrinol (Oxf), 42 (2), 199-203
DOI 10.1111/j.1365-2265.1995.tb01863.x, PubMed 7704964

Dahl E, Nordal KP, Halse J (1994)
Chronic renal failure: diagnostic measures before parathyroidectomy
Scand J Urol Nephrol, 28 (3), 291-4
DOI 10.3109/00365599409181281, PubMed 7817173

Hartmann A, Nordal KP, Svennevig J, Noddeland H, Pedersen T, Skarbøvik AJ, Fauchald P (1994)
Successful use of artificial lung (ECMO) and kidney in the treatment of a 20-year-old female with Wegener's syndrome
Nephrol Dial Transplant, 9 (3), 316-9
PubMed 8052441

Nordal KP, Talseth T, Dahl E, Attramadal A, Albrechtsen D, Halse J, Brodwall EK, Flatmark A (1985)
Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin?
Lancet, 2 (8447), 153-4
DOI 10.1016/s0140-6736(85)90254-5, PubMed 2862341

Theses

Dahl E, Nordal KP (1992)
Renal osteodystrophy in Norway: aspects of pathogenesis and treatment
Department of Surgery B and Medicine B, The National Hospital, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 920100554